Literature DB >> 20557941

Determinants of agreement between the confocal scanning laser tomograph and standardized assessment of glaucomatous progression.

Gianmarco Vizzeri1, Christopher Bowd, Robert N Weinreb, Madhusudhanan Balasubramanian, Felipe A Medeiros, Pamela A Sample, Linda M Zangwill.   

Abstract

PURPOSE: To estimate the agreement of confocal scanning laser tomograph (CSLT), topographic change analysis (TCA) with assessment of stereophotographs, and standard automated perimetry (SAP) for detecting glaucomatous progression and to identify factors associated with agreement between methods.
DESIGN: Observational cohort study. PARTICIPANTS: We included 246 eyes of 167 glaucoma patients, glaucoma suspects, and ocular hypertensives.
METHODS: We included CSLT series (n ≥ 4 tests; mean follow-up, 4 years), stereophotographs, and SAP results in the analysis. The number of progressors by guided progression analysis (GPA, "likely progression"), progressors by masked stereophotographs assessment and progressors by TCA as determined for 3 parameters related to the number of progressed superpixels within the disc margin was determined. Agreement between progression by each TCA parameter, stereophotographs and GPA was assessed using the Kappa test. Analysis of variance with post hoc analysis was applied to identify baseline factors including image quality (standard deviation of the mean topography), disc size and disease severity (pattern standard deviation [PSD] and cup area) associated with agreement/nonagreement between methods. MAIN OUTCOME MEASURES: Agreement in assessing glaucomatous progression between the methods including factors associated with agreement/nonagreement between methods.
RESULTS: Agreement between progression by TCA and progression by stereophotographs and/or GPA was generally poor regardless of the TCA parameter and specificity cutoffs applied. For the parameters with the strongest agreement, cluster size in disc (CSIZE(disc)) and cluster area in disc (CAREA(disc)), kappa values were 0.16 (63.9%, agreement on 134 nonprogressing eyes and 23 progressing eyes) and 0.15 (64.1%, agreement on 135 nonprogressing eyes and 22 progressing eyes) at 99% cutoff. Most of the factors evaluated were not significantly associated with agreement/nonagreement between methods (all P > 0.07). However, SAP PSD was greater in the progressors by stereophotography only group compared with the progressors by TCA only group (5.8 ± 4.7 and 2.6 ± 2.2, respectively [P = 0.003] for CSIZE(disc) at 95% specificity and 5.4 ± 4.6 and 2.5 ± 2.3, respectively [P = 0.002] for CAREA(disc) at 99% specificity).
CONCLUSIONS: Agreement for detection of longitudinal changes between TCA, stereophotography, and SAP GPA is poor. Progressors by stereophotography only tended to have more advanced disease at baseline than progressors by TCA only.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20557941      PMCID: PMC2941775          DOI: 10.1016/j.ophtha.2010.02.002

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph.

Authors:  L M Zangwill; C Bowd; C C Berry; J Williams; E Z Blumenthal; C A Sánchez-Galeana; C Vasile; R N Weinreb
Journal:  Arch Ophthalmol       Date:  2001-07

2.  Detection of structural damage from glaucoma with confocal laser image analysis.

Authors:  H Uchida; L Brigatti; J Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-11       Impact factor: 4.799

3.  Longitudinal changes in the visual field and optic disc in glaucoma.

Authors:  Paul H Artes; Balwantray C Chauhan
Journal:  Prog Retin Eye Res       Date:  2005-01-24       Impact factor: 21.198

4.  Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement.

Authors:  Nicholas G Strouthidis; Andrew Scott; Neena M Peter; David F Garway-Heath
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

5.  Optic disc progression in glaucoma: comparison of confocal scanning laser tomography to optic disc photographs in a prospective study.

Authors:  Balwantray C Chauhan; Donna M Hutchison; Paul H Artes; Joseph Caprioli; Jost B Jonas; Raymond P LeBlanc; Marcelo T Nicolela
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

6.  Initial glaucomatous optic disk and retinal nerve fiber layer abnormalities and their progression.

Authors:  A Tuulonen; P J Airaksinen
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

7.  Optic nerve head topography in ocular hypertensive eyes using confocal scanning laser ophthalmoscopy.

Authors:  L M Zangwill; S van Horn; M de Souza Lima; P A Sample; R N Weinreb
Journal:  Am J Ophthalmol       Date:  1996-10       Impact factor: 5.258

8.  Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1998-10       Impact factor: 5.258

9.  Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.

Authors:  A Sommer; J Katz; H A Quigley; N R Miller; A L Robin; R C Richter; K A Witt
Journal:  Arch Ophthalmol       Date:  1991-01

10.  Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Bo Bengtsson; Leslie Hyman; Boel Bengtsson; Mohamed Hussein
Journal:  Arch Ophthalmol       Date:  2002-10
View more
  8 in total

1.  Influence of clinically invisible, but optical coherence tomography detected, optic disc margin anatomy on neuroretinal rim evaluation.

Authors:  Alexandre S C Reis; Neil O'Leary; Hongli Yang; Glen P Sharpe; Marcelo T Nicolela; Claude F Burgoyne; Balwantray C Chauhan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

Review 2.  In vivo imaging methods to assess glaucomatous optic neuropathy.

Authors:  Brad Fortune
Journal:  Exp Eye Res       Date:  2015-06-03       Impact factor: 3.467

3.  Optic nerve head morphology and visual field function in patients with AIDS and without infectious retinitis.

Authors:  Igor Kozak; Alka Ahuja; Sapna Gangaputra; Mark L Van Natta; Jennifer E Thorne; William R Freeman
Journal:  Ocul Immunol Inflamm       Date:  2012-06-14       Impact factor: 3.070

4.  Discrepancy between optic disc and nerve fiber layer assessment and optical coherence tomography in detecting glaucomatous progression.

Authors:  Jong Rak Lee; Kyung Rim Sung; Jung Hwa Na; Kilhwan Shon; Kyoung Sub Lee
Journal:  Jpn J Ophthalmol       Date:  2013-10-05       Impact factor: 2.447

5.  Agreement in identification of glaucomatous progression between the optic disc photography and Heidelberg retina tomography in young glaucomatous patients.

Authors:  Paraskeva Hentova-Sencanic; Ivan Sencanic; Goran Trajković; Marija Bozic; Nevena Bjelovic
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

6.  Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes.

Authors:  Na'ama Hammel; Akram Belghith; Christopher Bowd; Felipe A Medeiros; Lucie Sharpsten; Nadia Mendoza; Andrew J Tatham; Naira Khachatryan; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill
Journal:  Ophthalmology       Date:  2015-12-30       Impact factor: 12.079

7.  Predictive value of retrobulbar blood flow velocities in glaucoma suspects.

Authors:  Pilar Calvo; Antonio Ferreras; Vicente Polo; Noemi Güerri; Pilar Seral; Isabel Fuertes-Lazaro; Luis E Pablo
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-22       Impact factor: 4.799

8.  Comparison of Glaucoma Progression Detection by Optical Coherence Tomography and Visual Field.

Authors:  Xinbo Zhang; Anna Dastiridou; Brian A Francis; Ou Tan; Rohit Varma; David S Greenfield; Joel S Schuman; David Huang
Journal:  Am J Ophthalmol       Date:  2017-09-28       Impact factor: 5.258

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.